Endothelial lipase activity predicts high-density lipoprotein catabolism in hemodialysis: Novel phospholipase assay in postheparin human plasma

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 12, 2012, Pages 3033-3040

  Miksztowicz, Veronica ^a   McCoy, Mary G ^b   Schreier, Laura ^a   Cacciagiú, Leonardo ^a   Elbert, Alicia ^c   Gonzalez, Ana Inés ^a   Billheimer, Jeffrey ^b   Eacho, Patrick ^d   Rader, Daniel J ^b   Berg, Gabriela ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Kidney Disease Center and Arterial Hypertension (CEREHA)   (Argentina)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

chronic kidney disease; endothelial lipase; hepatic lipase; high density lipoprotein cholesterol; phospholipase activity

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; C REACTIVE PROTEIN; CREATININE; ENDOTHELIAL LIPASE; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UREA;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LIPOLYSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SN1 SPECIFIC PHOSPHOLIPASE ASSAY; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; ENZYME ASSAYS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPASE; MALE; MIDDLE AGED; PHOSPHOLIPASES; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RENAL DIALYSIS; WAIST CIRCUMFERENCE;

EID: 84870061894     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300110     Document Type: Article

References (41)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42:1050-1065. (Pubitemid 37413751)
2. Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, StehmanBreen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005;16:3728-3735. (Pubitemid 46211295)
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
4. Vaziri ND. Causes of dysregulation of lipid metabolism in chronic renal failure. Semin Dial. 2009;22:644-651.
5. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997;51:1678-1695. (Pubitemid 27252735)
6. González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients. Metab Clin Exp. 2003;52:116-121.
7. Qunibi WY. Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with endstage renal disease (ESRD). Kidney Int Suppl. 2005;95:S43-S50. (Pubitemid 43361556)
8. Kimura H, Miyazaki R, Imura T, Masunaga S, Shimada A, Mikami D, Kasuno K, Takahashi N, Hirano T, Yoshida H. Smaller lowdensity lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with lowdensity lipoprotein size. Nephrology (Carlton). 2011;16:558-566.
9. Wesolowski P, Saracyn M, Nowak Z, Wankowicz Z. Insulin resistance as a novel therapeutic target in patients with chronic kidney disease treated with dialysis. Pol Arch Med Wewn. 2010;120:54-57.
10. Brown RJ, Lagor WR, Sankaranaravanan S, Yasuda T, Quertermous T, Rothblat GH, Rader DJ. Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both highdensity lipoproteins and apolipoprotein Bcontaining lipoproteins. Circ Res. 2010;107:357-364.
11. McCoy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res. 2002;43:921-929. (Pubitemid 34602614)
12. Zambon A, Deeb SS, Bensadoun A, Foster KE, Brunzell JD. In vivo evidence of a role for hepatic lipase in human apoBcontaining lipoprotein metabolism, independent of its lipolytic activity. J Lipid Res. 2000;41:2094-2099. (Pubitemid 32039006)
13. Jin W, Marchadier D, Rader DJ. Lipases and HDL metabolism. Trends Endocrinol Metab. 2002;13:174-178. (Pubitemid 36733992)
14. Maugeais C, Tietge UJ, Broedl UC, Marchadier D, Cain W, McCoy MG, LundKatz S, Glick JM, Rader DJ. Dosedependent acceleration of highdensity lipoprotein catabolism by endothelial lipase. Circulation. 2003;108:2121-2126. (Pubitemid 37337589)
15. Mekki K, Prost J, Bouchenak M, Remaoun M, Belleville J. Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis. Atherosclerosis. 2003;169:269-277. (Pubitemid 37297473)
16. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. A novel endothelialderived lipase that modulates HDL metabolism. Nat Genet. 1999;21:424-428. (Pubitemid 29159582)
17. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med. 2006;3:e22.
18. Fujii H, Fukuda A, Tanaka M, Kojima Y, Ishida T, Hirata K, Fukagawa M. Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Am J Nephrol. 2008;28:974-981.
19. Skropeta D, Settasatian C, McMahon MR, Shearston K, Caiazza D, McGrath KC, Jin W, Rader DJ, Barter PJ, Rye KA. NGlycosylation regulates endothelial lipasemediated phospholipid hydrolysis in apoE and apoAIcontaining high density lipoproteins. J Lipid Res. 2007;48:2047-2057. (Pubitemid 47360624)
20. Jin W, Fuki IV, Seidah NG, Benjannet S, Glick JM, Rader DJ. Proprotein convertases [corrected] are responsible for proteolysis and inactivation of endothelial lipase. J Biol Chem. 2005;280:36551-36559. (Pubitemid 41587730)
21. Shimamura M, Matsuda M, Yasumo H, et al. Angiopoietinlike protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol. 2007;27:366-372. (Pubitemid 46143053)
22. Gugliucci A, Kinugasa E, Kotani K, Caccavello R, Kimura S. Serum paraoxonase 1 (PON1) lactonase activity is lower in endstage renal disease patients than in healthy control subjects and increases after hemodialysis. Clin Chem Lab Med. 2011;49:61-67.
23. Cheung AK, Parker CJ, Ren K, Iverius PH. Increased lipase inhibition in uremia: identification of prebetaHDL as a major inhibitor in normal and uremic plasma. Kidney Int. 1996;49:1360-1371.
24. Murase T, Cattran DC, Rubenstein B, Steiner G. Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metab Clin Exp. 1975;24:1279-1286.
25. Assmann G, Schriewer H, Schmitz G, Hägele EO. Quantification of highdensitylipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem. 1983;29:2026-2030. (Pubitemid 14203604)
26. Assmann G, Jabs HU, Kohnert U, Nolte W, Schriewer H. LDLcholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clin Chim Acta. 1984;140:77-83. (Pubitemid 14113704)
27. Eacho PI, FoxworthyMason PS, Harper RW, Lin H, Lopez JE, Richett ME. Chromogenic compound, United States Patent # 6,448,422 B1, 2002.
28. NilssonEhle P, Ekman R. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery. 1977;3: 194-200.
29. Berg GA, Siseles N, González AI, Ortiz OC, Tempone A, Wikinski RW. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause. 2001;8:51-57. (Pubitemid 32066580)
30. Vaziri ND, Yuan J, Ni Z, Nicholas SB, Norris KC. Lipoprotein lipase deficiency in chronic kidney disease is accompanied by downregulation of endothelial GPIHBP1 expression. Clin Exp Nephrol. 2012;16:238-243.
31. National Kidney Foundation. K/DOQI clinical practice guidelines for managing dyslipidemia in chronic kidney disease. Am J Kidney Dis. 2003;41:1-92.
32. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62:707-714. (Pubitemid 8110784)
33. Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR, Bergeron N, Lamarche B. Endothelial lipase is associated with inflammation in humans. J Lipid Res. 2006;47:2808-2813. (Pubitemid 44936094)
34. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase is increased in vivo by inflammation in humans. Circulation. 2008;117:678-685.
35. Klin M, Smogorzewski M, Ni Z, Zhang G, Massry SG. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J Clin Invest. 1996;97:2167-2173.
36. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int. 1992;41:1653-1661.
37. Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care. 2005;28:2181-2186. (Pubitemid 41242465)
38. Feingold KR, Memon RA, Moser AH, Shigenaga JK, Grunfeld C. Endotoxin and interleukin1 decrease hepatic lipase mRNA levels. Atherosclerosis. 1999;142:379-387. (Pubitemid 29059496)
39. da Costa JA, Ikizler TA. Inflammation and insulin resistance as novel mechanisms of wasting in chronic dialysis patients. Semin Dial. 2009;22:652-657.
40. Jin W, Sun GS, Marchadier D, Octtaviani E, Glick JM, Rader DJ. Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase. Circ Res. 2003;92:644-650. (Pubitemid 36417699)
41. Cacciagiú LD, González AI, Gomez Rosso L, Meroño T, De Marziani G, Elbert A, Berg G, Brites F, Schreier L. HDLassociated enzymes and proteins in hemodialysis patients. Clin Biochem. 2012;45:243-248.